Two or more significant life-events in 6-months are associated with lower rates of HIV treatment and virologic suppression among youth with HIV in Uganda and Kenya.
Two or more significant life-events in 6-months are associated with lower rates of HIV treatment and virologic suppression among youth with HIV in Uganda and Kenya.
复制标题
乌干达和肯尼亚艾滋病毒感染青年中,六个月内发生的两次或两次以上重大生活事件与艾滋病毒治疗和病毒学抑制率较低有关。
DOI:
10.1080/09540121.2022.2052260
复制
发表时间:
2023
期刊:
影响因子:
1.7
通讯作者:
Ruel,TheodoreD
中科院分区:
文献类型:
--
作者:
Mwangwa,Florence;Charlebois,EdwinD;Ayieko,James;Olio,Winter;Black,Douglas;Peng,James;Kwarisiima,Dalsone;Kabami,Jane;Balzer,LauraB;Petersen,MayaL;Kapogiannis,Bill;Kamya,MosesR;Havlir,DianeV;Ruel,TheodoreD
Youth living with HIV in sub-Saharan Africa have poor HIV care outcomes. We determined the association of recent significant life-events with HIV antiretroviral treatment (ART) initiation and HIV viral suppression in youth aged 15–24 years living with HIV in rural Kenya and Uganda. This was a cross-sectional analysis of 995 youth enrolled in the SEARCH Youth study. At baseline, providers assessed recent (within 6 months) life-events, defined as changes in schooling/employment, residence, partnerships, sickness, incarceration status, family strife or death, and birth/pregnancy, self-reported alcohol use, being a parent, and HIV-status disclosure. We examined the frequencies of events and their association with ART status and HIV viral suppression (<400 copies/ul). Recent significant life-events were prevalent (57.7%). Having>2 significant life-events (aOR = 0.61, 95% CI:0.45-0.85) and consuming alcohol (aOR = 0.61, 95% CI:0.43-0.87) were associated with a lower odds of HIV viral suppression, while disclosure of HIV-status to partner (aOR = 2.39, 95% CI:1.6-3.5) or to family (aOR = 1.86, 95% CI:1.3-2.7), being a parent (aOR = 1.8, 95% CI:1.2-2.5), and being single (aOR = 1.6, 95% CI:1.3-2.1) had a higher odds. This suggest that two or more recent life-events and alcohol use are key barriers to ART initiation and achievement of viral suppression among youth living with HIV in rural East Africa.Trial registration:ClinicalTrials.gov identifier: NCT03848728..